Sabaa International Company for Pharmaceutical and Chemical News - Mubasher Info
Mubasher TV
Contact Us Advertising   العربية

Sabaa International Company for Pharmaceutical and Chemical (SIPC)

Last update: 25 December 02:29 PM market time.
2.84
-0.03
-1.05%
Open 2.87
Previous Close 2.87
High 2.89
Low 2.83
Stock Statistics
Volume 1,466,071
Turnover 4,184,174.25
All data are 15 minutes late during market session

News

The capital will be increased by issuing 6 million bonus shares
19 May 2021 01:09 PM Sabaa Pharmaceutical's shareholders approve capital raise via bonus issue
Cairo – Mubasher: The extraordinary general meeting (EGM) of Sabaa International Company for Pharmaceutical and Chemical Industry approved the board’s proposal to raise the issued and paid-up capital to EGP 100 million from EGP 88 million. The …
The pharmaceutical company plans to increase its issued capital to EGP 100 million
7 April 2021 04:50 PM FRA approves Sabaa Pharmaceutical's capital raise
Cairo – Mubasher: The Egyptian Financial Regulatory Authority (FRA) approved the publication of the disclosure form submitted by Sabaa International Company for Pharmaceutical and Chemical Industry to proceed with the capital raise. The …
The pharmaceutical company’s revenues rose to EGP 69.75 million
21 March 2021 01:16 PM Sabaa Pharmaceutical's profit leaps 76% in 2020 initial results
Cairo – Mubasher: The net profits of Sabaa International Company for Pharmaceutical and Chemical Industry jumped by 76% year-on-year (YoY) to EGP 15.14 million in 2020, compared to EGP 8.58 million, the unaudited financial results showed.   The …
The registration procedures are projected to be complete within three months
22 July 2020 01:38 PM Sabaa expected to produce 250K doses of Favipiravir in 6M
Cairo – Mubasher: Sabaa International Company for Pharmaceutical and Chemical Industry is expected to produce 250,000 doses of Favipiravir for the treatment of coronavirus (COVID-19) during six months starting from the date of production.   The …
The drug will be manufactured at the company’s factory in Kafr El-Sheikh
13 July 2020 11:19 AM Sabaa Pharmaceutical obtains initial approval to register COVID-19 drug
Cairo – Mubasher: Sabaa International Company for Pharmaceutical and Chemical Industry has received an initial approval from the Egyptian Drug Authority (EDA) to register a drug product (Favipiravir 200 mg), a potential treatment for coronavirus …
The Egyptian Exchange (Photo credit: Mubasher)
9 May 2017 11:09 AM Sabaa Pharmaceutical approves treasury stocks sale
Cairo – Mubasher: Sabaa International Company for Pharmaceutical and Chemical Industry said Tuesday that it has approved the selling of 164,600 treasury stocks. The sale will start on 11 May and will end on 9 June via the Roots Stock Brokerage …
(Photo credit: Arabianeye - Reuters)
9 March 2017 10:45 AM Sabaa Pharmaceutical EGM to mull capital hike 1 April
Cairo – Mubasher: Sabaa International Company for Pharmaceutical and Chemical Industry said that its extraordinary general meeting (EGM) will discuss on 1 April a proposal to increase the capital from EGP 60 million to EGP 66 million. On the same …
(Photo credit: Arabianeye - Reuters)
28 February 2017 00:01 PM Sabaa Pharmaceutical proposes 3m bonus shares
Cairo – Mubasher: Sabaa International Company for Pharmaceutical and Chemical Industry’s board of directors has recommended the distribution of 1-for-10 bonus shares, totalling 3 million bonus shares worth EGP 6 million. Thus, the company’s issued …
(Photo Credit: Arabianeye-Reuters)
19 February 2017 11:43 AM EGX suspends trading on 3 stocks
Cairo – Mubasher: The Egyptian Exchange’s (EGX) board on Sunday decided to suspend all trading in terms of offers and orders on three companies’ stocks, which have not yet released their financial statements for the period which ended on 31 …
Sabaa International profits decline 4.8% in 9M
7 November 2016 01:17 PM Sabaa International profits decline 4.8% in 9M
Cairo – Mubasher: Sabaa International Company for Pharmaceutical reported a decline of 4.8% in net profits for the first nine months of 2016. The company saw net profits of EGP 1.53 million for the nine – month period ended September 2016, down …
Three Egyptian listed companies finish off stock buyback
13 October 2016 04:08 PM Three Egyptian listed companies finish off stock buyback
Cairo – Mubasher: Each of Elsaeed Contracting and Real Estate Investment, Sabaa International Company for Pharmaceutical and Chemical Industry and Giza General Contracting and Real Estate Investment have completed buying back treasury stocks. …
Sabaa Pharmaceutical completes expansions worth EGP22m
26 September 2016 01:08 PM Sabaa Pharmaceutical completes expansions worth EGP22m
Cairo – Mubasher: Sabaa International for Pharmaceutical and Chemical Industry Co. said it finished off expansions worth EGP 22 million at its plant in Kafr el sheikh. The expansions comprise the installation of new production lines and are …
Q2 net profits reached EGP 524,070 - Photo Credit: Reuters
1 August 2016 01:58 PM Sabaa Pharmaceutical Q2 profits down 10%
Cairo – Mubasher: Sabaa International Company for Pharmaceutical and Chemical Industry reported a 10.3% decline in the second quarter’s net profits, according to a bourse filing. Thus, net profits reached EGP 524,070 in Q2, compared with EGP …
Photo Credit: Arabianeye - Reuters
28 December 2015 11:52 AM Sabaa Pharmaceutical eyes EGP60m revenues in 2016
Cairo - Mubasher: Sabaa International Company for Pharmaceutical and Chemical Industry said it looks forward to raising its revenues to EGP 60 million in 2016. The company's estimated revenues for 2015 stands at EGP 40 million. The drug firm will …
Photo Credit: Arabianeye - Reuters
9 December 2015 02:10 PM Sabaa Pharmaceutical plans to amend capital
Cairo-Mubasher: Sabaa International Company for Pharmaceutical and Chemical Industry said on Wednesday that it plans to amend articles No. 6 and 7 of the articles of association related to capital. The board mandated Chairman Abdulnabi El-Beili …
Photo Credit: Arabianeye - Reuters
29 November 2015 00:45 PM Sabaa Pharmaceutical eyes EGP 4m in revenues from selling Hepatitis C Drug
Cairo – Mubasher: Sabaa Pharmaceutical said it expects revenues of nearly EGP 4 million from selling 2,500 units of SoviHep Hepatitis C Drug. The revenues are expected to be reflected at the financial statements of the financial period that will …
Photo Credit: Arabianeye-Reuters
29 March 2015 04:30 PM Sabaa Pharm shareholders OK bonus shares
Sabaa International Company for Pharmaceutical Co.’s ordinary general meeting approved to distribute 5 million bonus shares, with a one-for-five share allocation, at a total value of EGP 10 million.Meanwhile, the company's extraordinary general …
Photo Credit: Arabianeye-Reuters
9 March 2015 02:55 PM Three companies get EGX nod on capital hike
The Egyptian Stock Exchange (EGX) announced Monday that it has approved the capital increase of three listed companies.EGX approved the capital hike of Pioneers Holding to EGP 3.35 billion. The capital increase will be effected through issuance of …
17 September 2014 05:04 PM Sabaa Pharmaceutical plunges to record low
The stock of Sabaa International Company for Pharmaceutical and Chemical Industry (SIPC) has plummeted during Wednesday’s session to its lowest level since debut. It fell 2.6% to EGP6.54.More than 3,000 shares in the company were …
3 September 2014 11:16 AM Sabaa Pharmaceutical chairman buys 2% at EGP3.5 mln
Ahmed Al Otaifi, board member, Sabaa International Company for Pharmaceutical and Chemical Industry (SIPC), said the company’s chairman and major shareholder Abdel Nabei El Beily, bought 500 thousand shares, or 2% in the company on …
13 August 2014 03:59 PM Sabaa Pharmaceutical H1 profit jumps 23% to EGP1 mln
Sabaa International Company for Pharmaceutical and Chemical Industry (SIPC) posted EGP 1 million net profit for H1-14, with 23% rise year-over-year from EGP 821 thousand net profit.Q1-14 profit had amounted to EGP 832.6 thousand, compared …